Evidence mapPaperPMID 41235334Full record

ArticleFrontiers in cardiovascular medicine2025

Association between the atherogenic index of plasma, body mass index, and cardiovascular diseases in Chinese middle and old-aged adults: a mediation analysis.

Yirui Xu, Mengping Liu, Wenbo Yang, Wenjiao Zhang, Heze Fan, Yu Xu, Juan Zhou, Zuyi Yuan

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yirui XuDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Mengping LiuDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wenbo YangDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wenjiao ZhangDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Heze FanDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Yu XuDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Juan ZhouDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zuyi YuanDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence has emerged that suggests the atherogenic index of plasma (AIP), as determined by blood lipid levels, is a valuable predictor of the onset of cardiovascular diseases. The correlation between AIP and cardiovascular diseases may be facilitated by body mass index (BMI), as atherosclerosis is prevalent in overweight and obese populations. In order to assess the combined predictive value of the AIP and BMI in predicting outcomes associated with cardiovascular diseases, this study sought to determine if BMI mediates the relationship between the AIP and cardiovascular disease risk. Methods: Participants in this study were those who were without cardiovascular diseases at baseline and were members of the China Health and Retirement Longitudinal Study (CHARLS). We performed adjusted regression analysis and mediation. AIP was calculated using the logarithm of the ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C). The estimated body weight and height were used to calculate the BMI. Results: This study included 5468 participants. Cardiovascular diseases were highly linked with both BMI and AIP. In contrast to those with a lower AIP (median level) and BMI <24, those with an elevated AIP and increased BMI presented a higher risk for developing cardiovascular conditions (HR: 1.789; 95% CI: 1.491-2.147). Additionally, about 30.57% of the connection between AIP and cardiovascular diseases was strongly mediated by BMI. Conclusions: Among Chinese adults in their middle and advanced years, the AIP and BMI jointly have been associated to a higher risk of cardiovascular diseases, and BMI could serve as a mediator in this connection.

Indexed as

atherogenic index of plasmabody mass indexcardiovascular diseasesCHARLSmediation analysis

Identifiers

PMID41235334
PMCPMC12606225

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.